Literature DB >> 23695605

Monoclonal gammopathy of undetermined significance.

Sébastien Anguille, Christian Bryant.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23695605      PMCID： PMC3796601          DOI： 10.1503/cmaj.122090

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Monoclonal gammopathy of undetermined significance: a consensus statement.

Authors:  James R Berenson; Kenneth C Anderson; Robert A Audell; Ralph V Boccia; Morton Coleman; Meletios A Dimopoulos; Matthew T Drake; Rafael Fonseca; Jean-Luc Harousseau; Douglas Joshua; Sagar Lonial; Ruben Niesvizky; Antonio Palumbo; G David Roodman; Jesus F San-Miguel; Seema Singhal; Donna M Weber; Maurizio Zangari; Eric Wirtschafter; Ori Yellin; Robert A Kyle
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

2.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; L Joseph Melton; Colin L Colby; Terry M Therneau; Raynell Clark; Shaji K Kumar; Arthur Bradwell; Rafael Fonseca; D F Jelinek; S Vincent Rajkumar
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

Review 3.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

4.  Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection.

Authors:  Panagiotis A Konstantinopoulos; Liron Pantanowitz; Bruce J Dezube
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

Review 5.  Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Authors:  R A Kyle; B G M Durie; S V Rajkumar; O Landgren; J Blade; G Merlini; N Kröger; H Einsele; D H Vesole; M Dimopoulos; J San Miguel; H Avet-Loiseau; R Hajek; W M Chen; K C Anderson; H Ludwig; P Sonneveld; S Pavlovsky; A Palumbo; P G Richardson; B Barlogie; P Greipp; R Vescio; I Turesson; J Westin; M Boccadoro
Journal:  Leukemia       Date:  2010-04-22       Impact factor: 11.528

6.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.